48:23 21-180/P 48:24 21-180/E (REG .01-1) EMERGENCY ACTION IN EFFECT 11/1/2021—4/30/2022

09.10.03.01-1

.01-1 Restricted Use of Medications and Other Substances.

The use of the following medications and other substances is permitted if quantitated at not more than the specified thresholds:

A. Acepromazine quantitated at not more than 10 nanograms per milliliter of HEPS in urine;

B. Albuterol quantitated at not more than 1 nanogram per milliliter of urine;

C. Butorphanol quantitated at not more than 300 nanograms per milliliter of total butorphanol in urine, or 2 nanograms per milliliter of free butorphanol in blood plasma or serum;

D. Caffeine quantitated at not more than 100 nanograms per milliliter of blood plasma or serum;

E. Cetirizine quantitated at not more than 6 nanograms per milliliter of blood plasma or serum;

F. Cimetidine quantitated at not more than 400 nanograms per milliliter of blood plasma or serum;

G. Cobalt quantitated at not more than 25 nanograms per milliliter of blood plasma or serum;

H. Dantrolene qunatitated at not more than 100 picrograms per milliliter of 5-hydroxydantrolene in blood plasma or serum;

I. Detomidine quantitated at not more than 2 nanograms per milliliter of carboxydetomidine in urine, or 1 nanogram of detomidine per milliliter of blood plasma or serum;

J. Dimethlysulfoxide (DMSO) quantitated at not more than 10 micrograms per milliliter of blood plasma or serum;

K. Flunixin quantitated at not more than 5 nanograms per milliliter of blood plasma or serum;

L. Furosemide (Lasix), as provided in Regulation .08 of this chapter;

M. Gamma aminobutyric acid quantitated at not more than 110 nanograms per milliliter of blood plasma or serum;

N. Glycopyrrolate quantitated at not more than 3 picograms per milliliter of blood plasma or serum;

O. Guaifenesin quantitated at not more than 12 nanograms per milliliter of blood plasma or serum;

P. Ketoprofen quantitated at not more than 2 nanograms per milliliter of blood plasma or serum;

Q. Lidocaine quantitated at not more than 20 picograms per milliliter of total 3-hydroxylidocaine in blood plasma or serum;

R. Mepivacaine quantitated at not more than 10 nanograms per milliliter of total hydroxymepivacaine in urine, or the limit of detection of mepivacaine in blood plasma or serum;

S. Methocarbamol quantitated at not more than 1 nanogram per milliliter of blood plasma or serum;

T. Methylprednisolone quantitated at not more than 100 picograms per milliliter of blood plasma or serum;

U. Omeprazole quantitated at not more than 10 nanograms per milliliter of blood plasma or serum;

V. Phenylbutazone quantitated at not more than 0.3 micrograms per milliliter of the blood plasma or serum;

W. Procaine Penicillin quantitated at not more than 25 nanograms per milliliter of blood plasma or serum;

X. Ranitidine quantitated at not more than 40 nanograms per milliliter of blood plasma or serum;

Y. Xylazine quantitated at not more than 200 picigrams per milliliter of blood plasma or serum;

Z. Nandrolone quantitated at not more than 1 nanogram per milliliter of urine taken from a gelding, filly, or mare;

AA. Boldenone quantitated at not more than 15 nanograms per milliliter of urine taken from a colt or horse;

BB. Testosterone quantitated at not more than 20 nanograms per milliliter of urine taken from a gelding; and

CC. Testosterone quantitated at not more than 55 nanograms per milliliter of urine taken from a filly or mare.